{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:37:16Z","timestamp":1789432636111,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:00:00Z","timestamp":1538784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00415-018-9082-6","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:58:01Z","timestamp":1538787481000},"page":"2906-2915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients"],"prefix":"10.1007","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-5439","authenticated-orcid":false,"given":"Johannes","family":"Dorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makbule","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,6]]},"reference":[{"issue":"3","key":"9082_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Bergh Van den","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 17(3):356\u2013363","journal-title":"Eur J Neurol"},{"issue":"9","key":"9082_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","volume":"13","author":"L Querol","year":"2017","unstructured":"Querol L, Devaux J, Rojas-Garcia R, Illa I (2017) Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications. Nat Rev Neurol 13(9):533\u2013547","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"9082_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jns.12237","volume":"22","author":"I Illa","year":"2017","unstructured":"Illa I (2017) ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components. J Peripher Nerv Syst 22(4):418\u2013424","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"9082_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/157015909790031166","volume":"7","author":"S Jacob","year":"2009","unstructured":"Jacob S, Rajabally YA (2009) Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Curr Neuropharmacol 7(4):337\u2013342","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"9082_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000367682","volume":"38","author":"S Zollner","year":"2014","unstructured":"Zollner S, Pablik E, Druml W, Derfler K, Rees A, Biesenbach P (2014) Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two. Blood Purif 38(2):160\u2013166. \n                    https:\/\/doi.org\/10.1159\/000367682","journal-title":"Blood Purif"},{"issue":"6","key":"9082_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jca.20317","volume":"26","author":"W Kohler","year":"2011","unstructured":"Kohler W, Bucka C, Klingel R (2011) A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. J Clin Apher 26(6):347\u2013355. \n                    https:\/\/doi.org\/10.1002\/jca.20317","journal-title":"J Clin Apher"},{"issue":"6","key":"9082_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jca.21546","volume":"32","author":"I Lieker","year":"2017","unstructured":"Lieker I, Slowinski T, Harms L, Hahn K, Klehmet J (2017) A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy. J Clin Apher 32(6):486\u2013493","journal-title":"J Clin Apher"},{"issue":"5","key":"9082_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s1567-5688(09)71827-6","volume":"10","author":"R Klingel","year":"2009","unstructured":"Klingel R, Heibges A, Fassbender C (2009) Plasma exchange and immunoadsorption for autoimmune neurologic diseases\u2014current guidelines and future perspectives. Atheroscler Suppl 10(5):129\u2013132. \n                    https:\/\/doi.org\/10.1016\/s1567-5688(09)71827-6","journal-title":"Atheroscler Suppl"},{"issue":"5","key":"9082_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"IS Merkies","year":"2002","unstructured":"Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72(5):596\u2013601","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9082_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mus.24207","volume":"50","author":"A Breiner","year":"2014","unstructured":"Breiner A, Barnett C, Bril V (2014) INCAT disability score: a critical analysis of its measurement properties. Muscle Nerve 50(2):164\u2013169","journal-title":"Muscle Nerve"},{"issue":"3","key":"9082_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1529-8027.2010.00274.x","volume":"15","author":"IS Merkies","year":"2010","unstructured":"Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C (2010) Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst 15(3):208\u2013215","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"9082_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000331011","volume":"66","author":"N Galldiks","year":"2011","unstructured":"Galldiks N, Burghaus L, Dohmen C, Teschner S, Pollok M, Leebmann J, Frischmuth N, Hollinger P, Nazli N, Fassbender C, Klingel R, Benzing T, Fink GR, Haupt WF (2011) Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment. Eur Neurol 66(4):183\u2013189. \n                    https:\/\/doi.org\/10.1159\/000331011","journal-title":"Eur Neurol"},{"issue":"3","key":"9082_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.transci.2005.07.010","volume":"33","author":"LH Zinman","year":"2005","unstructured":"Zinman LH, Sutton D, Ng E, Nwe P, Ngo M, Bril V (2005) A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy. Transfus Apher Sci 33(3):317\u2013324. \n                    https:\/\/doi.org\/10.1016\/j.transci.2005.07.010","journal-title":"Transfus Apher Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9082-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T19:23:27Z","timestamp":1570303407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9082-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,6]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9082"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9082-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,6]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JD reports personal fees from Fresenius Medical Care GmbH and Fresenius Medical Care Deutschland GmbH, outside the submitted work. JD and HT report research and sponsoring grants from Fresenius Medical Care GmbH and Fresenius Medical Care Deutschland GmbH, outside the submitted work. MS has received honoraria for speaking and\/or travel grants from Bayer, Biogen, and TEVA, and research funding from the Hertha-Nathorff-Program and University of Ulm; none related to this study. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study has been approved by the local ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients were extensively informed about the procedure, its risks, and possible therapeutic alternatives, and gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}